For Treatment-Naive Melanoma Patients, Nivolumab May Hold Added Benefit
News
According to a recently released collection of papers (dossier) by the Institute for Quality and Efficiency in Health Care (IQWiG), use of the drug Nivolumab (trade name: Opdivo) may be ... Read more